18 June 2002
Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record - Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy
Stanisław J Konturek, Piotr C Konturek, Władysław Bielański, Krzysztof Lorens, Edward Sito, Jan W Konturek, Sławomir Kwiecień, Andrzej Bobrzyński, Teresa Pawlik, Danuta Karcz, Hany Areny, Tomasz StachuraMed Sci Monit 2002; 8(6): CS43-59 :: ID: 420805
Abstract
BACKGROUND: Zollinger-Ellison syndrome is a very rare disease caused bytumor with gastrin producing cells accompanied by hypergastrinemia leading to gastric hypersecretionand peptic ulcers and their complications.CASE STUDY: Female case of gastrinoma (Zollinger-Ellison syndrome;Z-E) with a record of 38 yrs of survival. Acute gastro-duodenal ulcers started at 28 yr of age and Z-Ewas diagnosed by using gastrin assays. Basal and maximal acid outputs and ratio of basal/maximal outputswere away over normal limits. Because of ulcer recurrence and complications, patient was subjected toseveral gastric surgeries but refused total gastrectomy. She was also treated with many H2-receptor (R)antagonists and proton-pump inhibitors (PPI), each new drug being initially highly effective but thenshowing declining efficacy except when PPI, lansoprazole was used. The gastrin level rose in the courseof disease from initial high value of 2000 pg/mL to the extreme 4500 ng/mL at present. During the last2 yrs, metastasis mainly to liver developed and they were successfully treated by synthetic octapeptidederivative of somatostatin and, as a result, metastatis partly reduced and plasma gastrin drasticly decreased.Biopsy taken from liver metastasis showed the presence of typical gastrinoma cells with gastrin and chromogranin,while that from oxyntic mucosa revealed the ECL-cell hyperplasia with carcinoid tumors and unexpectedgastric atrophy.CONCLUSIONS: This phenomenal case described in this article might be the new proven evidenceneeded by gastroenterologists to overturn the traditional treatment using total gastrectomy as a treatmentof choice to the partial gastrectomy combined with proton pump inhibitors.
Keywords: Anti-Ulcer Agents, Carcinoid Tumor, Gastrinoma, Histamine H2 Antagonists, Survivors, Zollinger-Ellison Syndrome
Editorial
01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-SmokersDOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
In Press
Clinical Research
Immune Dysregulation in Acute Herpes Zoster: Predictive Factors for Postherpetic NeuralgiaMed Sci Monit In Press; DOI: 10.12659/MSM.944688
Clinical Research
Inflammatory Biomarkers from Blood Counts as Prognostic Tools in Metastatic Esophageal CancerMed Sci Monit In Press; DOI: 10.12659/MSM.947202
Laboratory Research
Comparison of Color Stability Between Single-Shade and Conventional Composite Resins Following Immersion in...Med Sci Monit In Press; DOI: 10.12659/MSM.946784
Clinical Research
Evaluation of Knowledge, Attitudes, and Practices Toward Thyroid Nodules in 456 Patients with Thyroid NodulesMed Sci Monit In Press; DOI: 10.12659/MSM.945732
Most Viewed Current Articles
17 Jan 2024 : Review article 6,966,841
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 701,694
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 25,087
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 19,746
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912